Research ContextGuideline / official boundaryncbi.nlm.nih.gov
Cannabinoid Antiemetic Therapy — StatPearls (2025)
Oncology / Anti-Proliferative · Supportive Oncology — CINV · Dronabinol, nabilone
Validated — Guideline/official boundary source
Clinical wording: “Do not use cannabis/cannabinoids as cancer-directed treatment outside a clinical trial.”
DOI/ID: NBK535430Source ID: RES-0082
Research ContextGuideline / official boundaryaccessdata.fda.gov
EPIDIOLEX prescribing information (2025)
Safety / Guidelines · Liver monitoring / CBD · Cannabidiol
Validated — Guideline/official boundary source
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
Source ID: RES-0223
Clinical GuidelineGuideline / official boundaryascopubs.org
ASCO Guideline (2024)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Validated — Guideline/official boundary source
Clinical wording: “Do not use cannabis/cannabinoids as cancer-directed treatment outside a clinical trial.”
DOI/ID: 10.1200/JCO.23.02596Source ID: RES-0001
Clinical GuidelineGuideline / official boundaryncbi.nlm.nih.gov
Cannabis (Marijuana) Overview — StatPearls (2024)
Safety / Guidelines · Clinical safety overview · Cannabis, cannabinoids
Validated — Guideline/official boundary source
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
DOI/ID: NBK430801Source ID: RES-0220
Clinical GuidelineGuideline / official boundarypmc.ncbi.nlm.nih.gov
Cannabis for the Treatment of Fibromyalgia: A Systematic Review (2023)
Anti-Inflammatory · Fibromyalgia · CBD, THC, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 37371716PMCID: PMC10295750Source ID: RES-0186
Clinical GuidelineGuideline / official boundarypubmed.ncbi.nlm.nih.gov
Nabiximols as add-on treatment for MS-associated spasticity (2023)
Neuroprotective · MS spasticity · THC:CBD oromucosal spray
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 37519000Source ID: RES-0151
Clinical GuidelineGuideline / official boundarypmc.ncbi.nlm.nih.gov
Cannabidiol in Treatment of Autism Spectrum Disorder: Systematic Review (2022)
Neuroprotective · Autism / ASD · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC9509693Source ID: RES-0239
Clinical GuidelineGuideline / official boundarypubmed.ncbi.nlm.nih.gov
Use of cannabidiol in Lennox-Gastaut and Dravet syndrome epilepsy (2022)
Neuroprotective · Epilepsy · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 36417631Source ID: RES-0149
Clinical GuidelineGuideline / official boundarypmc.ncbi.nlm.nih.gov
Cannabidiol Clinical Trial Outcomes — Parkinson's, Seizures via CB2, 5-HT1A (2020)
Neuroprotective · Parkinson's Disease · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32161538PMCID: PMC7053164Source ID: RES-0112
Clinical GuidelineGuideline / official boundarypmc.ncbi.nlm.nih.gov
Cannabinoids for People with ASD: A Systematic Review (2020)
Neuroprotective · ASD Systematic Review · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7563787Source ID: RES-0139
Clinical GuidelineGuideline / official boundarypmc.ncbi.nlm.nih.gov
Efficacy of CBD for Pain Management: A Randomized Controlled Trial (2020)
Pain / Analgesic · Clinical RCT · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7488911Source ID: RES-0146
Verified SourceGuideline / official boundarypubmed.ncbi.nlm.nih.gov
CBD in Autoimmune and Inflammatory Diseases (2019)
Anti-Inflammatory · Autoimmune · CBD
Validated — Guideline/official boundary source
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 31504204Source ID: RES-0137
Clinical GuidelineGuideline / official boundaryncbi.nlm.nih.gov
Cancer — Health Effects of Cannabis and Cannabinoids (2017)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Cannabis, cannabinoids
Validated — Guideline/official boundary source
Clinical wording: “Do not use cannabis/cannabinoids as cancer-directed treatment outside a clinical trial.”
DOI/ID: NBK425761Source ID: RES-0088
Clinical GuidelineGuideline / official boundaryncbi.nlm.nih.gov
Summary — The Health Effects of Cannabis and Cannabinoids (2017)
Neuroprotective · Sleep disturbance · Cannabinoids, nabiximols
Validated — Guideline/official boundary source
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
DOI/ID: NBK425741Source ID: RES-0152
Research ContextGuideline / official boundaryncbi.nlm.nih.gov
Therapeutic Effects of Cannabis and Cannabinoids — NCBI Bookshelf (2017)
Oncology / Anti-Proliferative · Supportive Oncology — Pain · Cannabis, cannabinoids
Validated — Guideline/official boundary source
Clinical wording: “Cannabinoid antiemetic evidence is mainly adjunct/salvage supportive care under oncology supervision.”
DOI/ID: NBK425767Source ID: RES-0093
Clinical GuidelineGuideline / official boundarypubmed.ncbi.nlm.nih.gov
CBD for Anxiety Disorders: Systematic Review and Meta-analysis
Sleep / Anxiety / QOL · Anxiety · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 36370842Source ID: RES-0231
Clinical GuidelineGuideline / official boundarypubmed.ncbi.nlm.nih.gov
Cannabinoids and Sleep: Systematic Review of Current Evidence
Sleep / Anxiety / QOL · Insomnia · CBD, THC, CBN
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 25271780Source ID: RES-0241
Clinical GuidelineGuideline / official boundaryncbi.nlm.nih.gov
Cannabis and Cannabinoids (PDQ®) — NCI/NCBI (Updated)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Cannabis, cannabinoids, CBD, THC
Validated — Guideline/official boundary source
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
DOI/ID: NBK65875Source ID: RES-0085
Research ContextGuideline / official boundarycancer.gov
NCI PDQ (Updated 2025)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Validated — Guideline/official boundary source
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
Source ID: RES-0055
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoids and Terpenes for Diabetes Mellitus — ECS Metabolic Homeostasis (2022)
Entourage Effect · Diabetes / Metabolic Syndrome · CBD, Terpenes
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 36280497Source ID: RES-0129
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoid Interactions with Cytochrome P450 Drug Metabolism (2021)
Safety / Guidelines · Drug interactions · 12 cannabinoids, CYP enzymes
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 34181150Source ID: RES-0221
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
CBD Anti-Metastatic Activity in Breast Cancer — Id-1 Gene Suppression (2007)
Oncology / Anti-Proliferative · Cancer — Breast · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 17938263Source ID: RES-0002
Research ContextClinical synthesispmc.ncbi.nlm.nih.gov
CBD efficacy in chronic neuropathic pain: systematic review
Oncology / Anti-Proliferative · Supportive Oncology — Pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7281088Source ID: RES-0095
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
CBD inhibits lung cancer invasion and metastasis
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 20331200Source ID: RES-0021
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Twak (Cinnamomum zeylanicum): NF-κB Inhibition, Glucose Metabolism
Anti-Inflammatory · Twak (Cinnamon) · Twak / Cinnamon
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 21711570Source ID: RES-0109
Research ContextHuman clinical evidencepubmed.ncbi.nlm.nih.gov
Vaporized Cannabis versus Placebo for Acute Migraine — CGRP Modulation (2024)
Anti-Inflammatory · Migraine · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 38405890Source ID: RES-0177
Verified SourceHuman clinical evidencepubmed.ncbi.nlm.nih.gov
Cannabidiol acts as molecular switch in innate immune cells to promote inflammation-resolving lipid mediators (2023)
Anti-Inflammatory · Anti-Inflammatory · CBD
Validated — peer-reviewed PubMed article with PMCID and DOI; supports anti-inflammatory mechanism, not disease cure.
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 37647900PMCID: PMC12233155DOI/ID: 10.1016/j.chembiol.2023.08.001Source ID: RES-0102
Verified SourceHuman clinical evidencepmc.ncbi.nlm.nih.gov
Cannabidiol acts as molecular switch in innate immune cells to promote inflammation-resolving lipid mediators (2023)
Anti-Inflammatory · Anti-Inflammatory · CBD
Validated — full-text PMC article; supports lipid-mediator anti-inflammatory mechanism only.
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 37647900PMCID: PMC12233155DOI/ID: 10.1016/j.chembiol.2023.08.001Source ID: RES-0103
Research ContextHuman clinical evidencepmc.ncbi.nlm.nih.gov
Mechanisms of Cannabidiol (CBD) in Cancer Treatment (2022)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC9220307Source ID: RES-0081
Research ContextHuman clinical evidencepmc.ncbi.nlm.nih.gov
CBD as a Potential Anti-Cancer Agent: Review of Clinical Trials (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC7546571Source ID: RES-0005
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
CBD as an Inducer of Apoptosis in Human Glioma Cells (2014)
Oncology / Anti-Proliferative · Cancer — Glioma / Brain · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 24373545Source ID: RES-0089
Research ContextPreclinical / mechanisticpmc.ncbi.nlm.nih.gov
Cannabidiol-Induced Apoptosis in Human Leukemia Cells (2013)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC3579246Source ID: RES-0029
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Cannabidiol Promotes Apoptosis in Human Breast Cancer Cells via CB2 (2011)
Oncology / Anti-Proliferative · Cancer — Breast · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 21566064Source ID: RES-0024
Research ContextHuman clinical evidencepubmed.ncbi.nlm.nih.gov
Cannabidiol reduces the anxiety induced by simulated public speaking (2011)
Neuroprotective · Social anxiety · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 21307846Source ID: RES-0153
Research ContextHuman clinical evidencepubmed.ncbi.nlm.nih.gov
Endometrial Cancer Apoptosis
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 29441458Source ID: RES-0068
Research ContextHuman clinical evidencepubmed.ncbi.nlm.nih.gov
Medical Cannabis for PTSD Symptoms: Randomized Controlled Trial
Sleep / Anxiety / QOL · PTSD · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 28207929Source ID: RES-0234
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective (2024)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Validated — peer-reviewed PubMed/PMC review; oncology claim must remain preclinical/mechanistic unless human endpoint exists.
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 38891847PMCID: PMC11171526DOI/ID: 10.3390/ijms25115659Source ID: RES-0091
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Cannabis, cannabinoids and health: a review of evidence (2024)
THC/CBD clinical context · THC/CBD clinical context · THC, CBD, medical cannabis
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC11910417Source ID: RES-0107
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Cannabidiol for Musculoskeletal Regenerative Medicine (2023)
Anti-Inflammatory · Musculoskeletal · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC10281618Source ID: RES-0178
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Cannabidiol goes nuclear: The role of PPARγ (2023)
CBD and PPARγ · CBD and PPARγ · CBD, PPARγ
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 36965374Source ID: RES-0105
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Endocannabinoid signaling in glioma (2023)
Oncology / Anti-Proliferative · Cancer — Glioma / Brain · THC, CBD
Validated — glioma-specific peer-reviewed source; use only for mechanistic research navigation, not therapeutic efficacy claims.
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 35322459PMCID: PMC9790654DOI/ID: 10.1002/1878-0261.13250Source ID: RES-0090
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Cannabidiol as a Treatment for Arthritis and Joint Pain (2022)
Anti-Inflammatory · Arthritis / Joint Pain · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 35999581PMCID: PMC9400326Source ID: RES-0184
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Cannabis on Multiple Sclerosis-Related Symptoms — CB2, ECS Immunomodulation (2022)
Immunomodulatory · Multiple Sclerosis · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC9148011Source ID: RES-0219
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Medical Cannabis Activity Against Inflammation: Active Compounds and Mechanisms (2022)
Anti-Inflammatory · Inflammation · CBD, THC, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 35614947PMCID: PMC9124761Source ID: RES-0188
Verified SourceScientific sourcejcannabisresearch.biomedcentral.com
CBD Use and Effectiveness: Real-World Evidence from Clinical Practice (2021)
Anti-Inflammatory · Chronic Pain · CBD, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
DOI/ID: 10.1186/s42238-021-00078-wSource ID: RES-0167
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD-Enriched Cannabis for Autism Spectrum Disorder (2021)
Neuroprotective · Autism / ASD · CBD, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC8675523Source ID: RES-0238
Verified SourceScientific sourcescience.org
Cannabidiol Inhibits SARS-CoV-2 Replication via Host ER Stress and Innate Immunity (2021)
Immunomodulatory · COVID-19 · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
DOI/ID: 10.1126/sciadv.abi6110Source ID: RES-0215
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Cannabinoids, the endocannabinoid system and pain (2021)
Anti-Inflammatory · Pain physiology · CB1, CB2, AEA, 2-AG
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC8819673Source ID: RES-0165
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Comparative Study of CBD and Conventional Painkillers (2021)
Pain / Analgesic · Comparative · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7929858Source ID: RES-0147
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Protective Effects of CBDV and CBG on BBB Under Ischemic Conditions (2021)
Neuroprotective · Ischemia / BBB · CBDV, CBG
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC8380798Source ID: RES-0142
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Therapeutic Efficacy of Cannabidiol — CB2, TRPV1, 5-HT1A Mechanisms (2021)
Anti-Inflammatory · Chronic Pain · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 33585159PMCID: PMC7880228Source ID: RES-0170
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Therapeutic Prospects of Cannabinoids in Immunomodulation of Autoimmune Diseases (2021)
Immunomodulatory · Autoimmune / Immune Modulation · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC8266560Source ID: RES-0218
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
A Balanced Approach for Cannabidiol Use in Chronic Pain (2020)
Anti-Inflammatory · Chronic Pain · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7204604Source ID: RES-0166
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Anti-inflammatory Potential of CBD in Psoriasis — Keratinocyte Hyperproliferation (2020)
Anti-Inflammatory · Psoriasis · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7320714Source ID: RES-0226
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Antioxidative and Anti-inflammatory Properties of Cannabidiol (2020)
Anti-Inflammatory · Inflammation · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 31881765PMCID: PMC7023045DOI/ID: 10.3390/antiox9010021Source ID: RES-0187
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD Anti-inflammatory Effects in Osteoarthritis — Chondroprotective via CB2 (2020)
Anti-Inflammatory · Osteoarthritis · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7339825Source ID: RES-0182
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD Reduces Diabetes-Related Inflammation — NLRP3 Inflammasome Inhibition (2020)
Anti-Inflammatory · Diabetes · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7345306Source ID: RES-0127
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD and its Efficacy in Reducing Neuroinflammation (2020)
Anti-Inflammatory · Neuroinflammation · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7309453Source ID: RES-0134
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD as Adjunctive Therapy for COVID-19: Cytokine Storm Reduction via CB2 (2020)
Anti-Inflammatory · COVID-19 · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7687018Source ID: RES-0214
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD for Inflammation Management in Cardiovascular Diseases (2020)
Anti-Inflammatory · Cardiovascular · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7326531Source ID: RES-0133
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action (2020)
Pain / Analgesic · CBD pharmacology · CBD, TRPV1, PPARγ, 5-HT1A, adenosine
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 33238607PMCID: PMC7700528DOI/ID: 10.3390/ijms21228870Source ID: RES-0106
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoid Signaling in Inflammation and Immune Modulation (2020)
Anti-Inflammatory · Cannabinoid Signaling · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32558899Source ID: RES-0132
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Cannflavin A: Anti-inflammatory Cannabis Flavonoid (2020)
Anti-Inflammatory · Cannflavin A · Cannflavin A, CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7324885Source ID: RES-0199
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Critical Review of THC and CBD in Multiple Sclerosis Treatment (2020)
Oxidative Stress / Mitochondrial · Multiple Sclerosis · THC, CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7593955Source ID: RES-0136
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Full-Spectrum Cannabis Extract in Treatment of Neuropathic Pain (2020)
Anti-Inflammatory · Neuropathic Pain · CBD, THC, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32201189Source ID: RES-0179
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Long-term Effects of CBD on Chronic Pain: A Cohort Study (2020)
Anti-Inflammatory · Chronic Pain · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7216052Source ID: RES-0169
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Review of the Endocannabinoid System (2020)
ECS Homeostasis · ECS overview · AEA, 2-AG, CB1, CB2
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7855189Source ID: RES-0116
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
The endocannabinoid system (2020)
ECS Homeostasis · ECS overview · Endocannabinoids, receptors, signaling
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32648908Source ID: RES-0117
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
The proposed mechanisms of action of CBD in epilepsy (2020)
Neuroprotective · Epilepsy mechanism · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32053110Source ID: RES-0150
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBD as Neuroprotectant in Neurodegenerative Disease — Mitochondrial Calcium (2019)
Neuroprotective · Neurodegeneration · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 31676992Source ID: RES-0111
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
The role of the endocannabinoid system in female reproductive tissues (2019)
ECS Homeostasis · Female reproduction · ECS, AEA, CB1/CB2
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC6332911Source ID: RES-0248
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBN as Oxidative Stress Protector (2018)
Oxidative Stress / Mitochondrial · CBN · CBN
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 30264520Source ID: RES-0144
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabidiol and Sleep Disorders — GABA-A Potentiation, REM Architecture (2018)
Sleep / Anxiety / QOL · Sleep Disorders · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 29381457Source ID: RES-0244
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoid Receptor 2 (CB2) in Immune Function (2017)
Immunomodulatory · THC Immune · THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 28521221Source ID: RES-0138
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoids in Attention Deficit Hyperactivity Disorder — Dopamine/Serotonin Balance (2017)
ECS Homeostasis · ADHD · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 28576350Source ID: RES-0236
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Quercetin Synergizes with CBD for Antioxidant Effects — NRF2 and ECS Pathway (2017)
Oxidative Stress / Mitochondrial · Quercetin · Quercetin, CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 27187333Source ID: RES-0235
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management (2017)
ECS Homeostasis · Endometriosis pain · ECS, endocannabinoids
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC5436335Source ID: RES-0247
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
An introduction to the endogenous cannabinoid system (2016)
ECS Homeostasis · ECS overview · AEA, 2-AG, CB1, CB2, FAAH, MAGL
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC4789136Source ID: RES-0115
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Beta-Caryophyllene: Interacts with CB2 as Dietary Cannabinoid (2016)
Anti-Inflammatory · Beta-Caryophyllene · Beta-Caryophyllene, CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC5083753Source ID: RES-0198
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBG in Neuroprotection and Glaucoma (2016)
Neuroprotective · CBG · CBG
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 27214202Source ID: RES-0141
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Therapeutic Potential of Non-Psychotropic CBD in Ischemic Stroke (2014)
Neuroprotective · Stroke · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC4036658Source ID: RES-0143
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBDA Bioavailability and Anti-inflammatory Properties — COX-2 Inhibition (2013)
Anti-Inflammatory · CBDA · CBDA
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23086348Source ID: RES-0185
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Limonene: Mood-enhancing properties (2013)
Entourage Effect · Limonene · Limonene + CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC712094Source ID: RES-0135
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
THC Effects on Mitochondrial Homeostasis (2013)
Oxidative Stress / Mitochondrial · THC Mitochondrial · THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23802894Source ID: RES-0145
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
THCA Anti-inflammatory Activity Without Psychoactivity (2012)
Anti-Inflammatory · THCA · THCA
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23145471Source ID: RES-0189
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Endocannabinoid Binding to the Cannabinoid Receptors (2010)
ECS Homeostasis · Cannabinoid receptor binding · AEA, 2-AG, CB1, CB2
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC4120766Source ID: RES-0114
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Endocannabinoid involvement in endometriosis (2010)
ECS Homeostasis · Endometriosis / pelvic pain · ECS, cannabinoids
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC2972363Source ID: RES-0246
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Targeting CB2 receptors and the endocannabinoid system for pain and inflammation (2009)
Anti-Inflammatory · Pain and immunity · CB2, endocannabinoids
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 19150370Source ID: RES-0118
Verified SourcePeer-reviewed reviewpmc.ncbi.nlm.nih.gov
The Endocannabinoid System and its Modulation by Cannabinoids — Foundational Review (2008)
ECS Homeostasis · General ECS · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC2541727Source ID: RES-0110
Verified SourcePreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Neuroprotective effect of cannabidiol on beta-amyloid-induced toxicity in PC12 cells (2004)
Neuroprotective · Alzheimer's · CBD
Validated — PubMed primary article; neuroprotective cell-model evidence only, not Alzheimer’s clinical treatment evidence.
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 15030397DOI/ID: 10.1111/j.1471-4159.2003.02327.xSource ID: RES-0140
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Beta-Caryophyllene CB2 agonist for inflammation
Anti-Inflammatory · Inflammation
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 18574142Source ID: RES-0193
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CB1 and CB2 Receptors in Female Reproductive Function
ECS Homeostasis · Reproductive Health · ECS
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC5418763Source ID: RES-0161
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBD Modulates Gut-Brain Axis for Digestion — FAAH Inhibition, ECS
Neuroprotective · Gut-Brain Axis · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32001368Source ID: RES-0131
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBD and Cannabinoids for Sleep Disorders: Large Clinical Case Series
Sleep / Anxiety / QOL · Sleep Disorders · CBD, CBN
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32350861Source ID: RES-0243
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBD and THC combination for rheumatoid arthritis pain
Anti-Inflammatory · Rheumatoid arthritis
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 33945704Source ID: RES-0196
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBD blocks multiple pain signaling pathways
Anti-Inflammatory · Chronic pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 26951675Source ID: RES-0171
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
CBD modulates ECS for chronic pain without tolerance
Anti-Inflammatory · Chronic pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC8450066Source ID: RES-0172
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBD modulates pain via TRPV1, 5-HT1A, CB2
Anti-Inflammatory · Chronic pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 27338416Source ID: RES-0173
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
CBG reduces acute inflammation better than CBD (IBD)
Anti-Inflammatory · IBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23415610Source ID: RES-0191
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoid therapy improves quality of life in arthritis
Anti-Inflammatory · Arthritis
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 33888504Source ID: RES-0190
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Cannabinoids and Gynecologic Pain: Dysmenorrhea Review
Pain / Analgesic · Dysmenorrhea · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 37713447Source ID: RES-0154
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Cannabis Sativa: Dermal Anti-inflammatory, Sebostatic via CB2 — Acne
Anti-Inflammatory · Acne / Seborrhoea · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 35535052PMCID: PMC9078861DOI/ID: 10.2147/JIR.S355489Source ID: RES-0225
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Daruharidra (Berberis aristata): Berberine, NF-κB Inhibitor — CannoDerma Ingredient
Anti-Inflammatory · Skin Infection · Berberine / Daruharidra
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 18442916Source ID: RES-0228
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
ECS Role in Stress Response and HPA Axis Regulation
ECS Homeostasis · Stress / HPA Axis · CBD, THC, ECS
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 31006082Source ID: RES-0237
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
ECS in Female Reproduction: Anandamide, CB1/CB2 and Menstrual Pain Modulation
ECS Homeostasis · Menstrual Pain · Anandamide, ECS
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 29458170Source ID: RES-0155
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Ela (Elettaria cardamomum): Anti-inflammatory, Antioxidant, COX Inhibition
Anti-Inflammatory · Ela (Cardamom) · Ela / Cardamom
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 24473231Source ID: RES-0108
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Endocannabinoid System and Endometriosis Pathophysiology
Anti-Inflammatory · Endometriosis · ECS, CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 38634996Source ID: RES-0156
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Endocannabinoid System in Polycystic Ovary Syndrome
ECS Homeostasis · PCOS · ECS, CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32743647Source ID: RES-0160
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Endocannabinoid System: Female Fertility and Pregnancy
ECS Homeostasis · Fertility · ECS
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 31193701Source ID: RES-0158
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Entourage Effect
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMID: 21749363Source ID: RES-0047
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Cannoflam — MCT Oil (Carrier)
Bioavailability / Delivery · Anti-inflammatory / Pain · Caprylic acid (C8), Capric acid (C10)
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 29580532Source ID: RES-0121
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Dental Sutraa — Clove (Syzygium aromaticum)
Pain / Analgesic · Anti-Microbial · Eugenol, Acetyl eugenol
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 16710900Source ID: RES-0123
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Femex28 (Ritu) — Ashoka (Saraca asoca)
Uterotonic; oxytocin modulation; dysmenorrhea relief · Menstrual Regulation · Catechins, Epicatechin, Flavonoids
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23661863Source ID: RES-0126
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Femex28 (Ritu) — Lodhra (Symplocos racemosa)
Anti-PCOD; ovarian regulation; estrogen modulation · Feminine Wellness · Loturine, Betulinic acid, Tannins
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 24197847Source ID: RES-0119
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Kumari Vijaya — Aloe vera (Kumari)
Anti-Inflammatory · Feminine Tonic · Aloin, Emodin, Glucomannan
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 17613130Source ID: RES-0120
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Madanakameshwari Rasayana — Ashwagandha (Withania somnifera)
Testosterone elevation +17%; cortisol −27.9%; sperm motility · Adaptogen / Aphrodisiac · Withanolides, Withaferin-A
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 19501822Source ID: RES-0125
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Madanakameshwari Rasayana — Safed Musli (Chlorophytum borivilianum)
ECS Homeostasis · Fertility · Saponins, Polysaccharides, Alkaloids
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 21284781Source ID: RES-0124
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Soukhya — Mandukaparni (Centella asiatica)
Neuroprotective · Neuroprotective · Asiaticoside, Madecassoside, Triterpenes
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 22379320Source ID: RES-0122
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Full-spectrum reduces inflammatory markers in RA
Anti-Inflammatory · Rheumatoid arthritis
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32612598Source ID: RES-0197
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Full-spectrum reduces neuropathic pain better than isolate
Anti-Inflammatory · Neuropathic pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 33888516Source ID: RES-0180
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Full-spectrum superior to CBD isolate for chronic pain
Anti-Inflammatory · Chronic pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32588042Source ID: RES-0174
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Kalamegh (Andrographis paniculata): NF-κB Inhibitor, Antiviral, Immunostimulant
Anti-Inflammatory · Respiratory Infection · Andrographis
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 22536283Source ID: RES-0216
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Linalool (Lavender / Sleep Sutra): GABA-A Anxiolytic and Sleep Onset Terpene
Entourage Effect · Insomnia · Linalool
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 12587690Source ID: RES-0242
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Medical Cannabis Use in Inflammatory Bowel Disease — ECS, CB1/CB2 in GI Tract
Anti-Inflammatory · IBD · CBD, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC6366240Source ID: RES-0128
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Menthol (Peppermint EO / Soukhya): TRPM8 Cooling Analgesic Mechanism
Pain / Analgesic · Topical Pain · Menthol / Peppermint EO
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 15612487Source ID: RES-0224
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Nardostachys jatamansi (Jatamansi): Anxiolytic via GABA Modulation
Sleep / Anxiety / QOL · Anxiety · Jatamansi
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 29934858Source ID: RES-0233
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Nardostachys jatamansi: Phytochemistry, Ethnomedicine and Pharmacology
Sleep / Anxiety / QOL · Insomnia · Jatamansi
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 38042505Source ID: RES-0113
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Pinene: Improves Alertness and Memory — ECS Terpene Synergy
Entourage Effect · Pinene · Alpha-Pinene
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC5424551Source ID: RES-0230
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Pippali (Piper longum): 20x Bioavailability Enhancement, Bronchial Relaxation
Bioavailability / Delivery · Bioavailability Enhancement · Piperine, Pippali
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23065130Source ID: RES-0217
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Role of the Endocannabinoid System in Gut Homeostasis and Intestinal Function
ECS Homeostasis · Gut Homeostasis · ECS
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC6561244Source ID: RES-0130
Verified SourcePeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Saraca asoca (Ashoka): Uterotonic, Menstrual Support — Comprehensive Review
Anti-Inflammatory · Menstrual Support · Ashoka
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 37390875Source ID: RES-0157
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Strengths and Limits of Cannabinoids
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMID: 34624678Source ID: RES-0070
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Symplocos racemosa (Lodhra): Anti-inflammatory, Skin Restorative
Anti-Inflammatory · Skin Inflammation · Lodhra
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 26851499Source ID: RES-0227
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
THC and CBD in inflammatory bowel disease pain
Anti-Inflammatory · IBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 31145464Source ID: RES-0192
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
THC:CBD 1:1 optimal for neuropathic pain
Anti-Inflammatory · Neuropathic pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 30025879Source ID: RES-0181
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
THCA shows potent anti-inflammatory effects
Anti-Inflammatory · Inflammation
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 24097268Source ID: RES-0195
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Terpenes in pain management: myrcene and limonene synergy
Anti-Inflammatory · Pain
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC6672708Source ID: RES-0183
Verified SourceScientific sourcepmc.ncbi.nlm.nih.gov
Triphala (Amalaki + Haritaki + Vibhitaki): Antioxidant, Skin Photoprotection
Oxidative Stress / Mitochondrial · Skin Health · Triphala
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7019938Source ID: RES-0229
Verified SourceScientific sourcepubmed.ncbi.nlm.nih.gov
Zingiber officinale (Shunti): 6-Gingerol, COX-2 and 5-LOX Inhibition
Anti-Inflammatory · Respiratory Infection · Shunti / Ginger
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 28246281Source ID: RES-0213
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Cannabinoids in Chronic Pain Management: A Review of the Evidence (2025)
Oncology / Anti-Proliferative · Supportive Oncology — Pain · THC, CBD, cannabinoids
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC11940634Source ID: RES-0094
Research ContextPeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Pharmacological effects of cannabidiol by transient receptor potential channels (2022)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD, TRPV1/TRP channels
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMID: 35483477Source ID: RES-0078
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Drug interactions with cannabinoids (2020)
Safety / Guidelines · Drug interactions · THC, CBD, warfarin, clobazam
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC7055953Source ID: RES-0222
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Opportunities for cannabis in supportive care in cancer (2019)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Cannabis, cannabinoids
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoid antiemetic evidence is mainly adjunct/salvage supportive care under oncology supervision.”
PMCID: PMC6676264Source ID: RES-0084
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Cannabinoids for treating inflammatory bowel diseases (2017)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Cannabinoids
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC5388177Source ID: RES-0086
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (2016)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Cannabis, ECS
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC5193087Source ID: RES-0087
Research ContextPeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Cannabidiol as a Potential Treatment for Anxiety Disorders (2015)
Neuroprotective · Anxiety disorders · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 26341731Source ID: RES-0148
Research ContextPeer-reviewed reviewpubmed.ncbi.nlm.nih.gov
Cannabinoids in treating chemotherapy-induced nausea and vomiting (2012)
Oncology / Anti-Proliferative · Supportive Oncology — CINV · Dronabinol, nabilone, cannabinoids
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoid antiemetic evidence is mainly adjunct/salvage supportive care under oncology supervision.”
PMID: 22491047Source ID: RES-0083
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Clinical Data Review
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC8864433Source ID: RES-0059
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
ECS Review
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC5877694Source ID: RES-0044
Research ContextPeer-reviewed reviewpmc.ncbi.nlm.nih.gov
Inflammation Review
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC2828614Source ID: RES-0054
Research ContextPeer-reviewed reviewnature.com
Nature Reviews Cancer
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
Source ID: RES-0056
Research ContextPreclinical / mechanisticmdpi.com
Mechanisms of Cannabidiol in Cancer Treatment: Mitochondrial Apoptosis (2022)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
Source ID: RES-0025
Research ContextPreclinical / mechanisticpmc.ncbi.nlm.nih.gov
Antitumor Effects of Cannabidiol in Preclinical Glioma Models (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC7572340Source ID: RES-0009
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Kaempferol: Anti-cancer Flavonoid Synergy with CBD — PPARγ and Apoptosis (2018)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Kaempferol, CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 29161914Source ID: RES-0048
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
CBD + Temozolomide: Synergistic Apoptosis in Glioblastoma (2013)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD, THC
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 23918706Source ID: RES-0028
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
THCA as Anti-proliferative Agent in Prostate Cancer — Non-psychoactive (2012)
Oncology / Anti-Proliferative · Cancer — Prostate · THCA
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 24237856Source ID: RES-0012
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Antitumorigenic Effects Beyond Apoptosis
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 19889794Source ID: RES-0062
Research ContextPreclinical / mechanisticpmc.ncbi.nlm.nih.gov
Apoptosis Research
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC4367590Source ID: RES-0030
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
CBD Lung Cancer Cell Apoptosis
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 23220503Source ID: RES-0063
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
CBD induces apoptosis in leukemia via CB2
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 16908594Source ID: RES-0020
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
CBG anti-proliferative in colon cancer via TRPM8
Oncology / Anti-Proliferative · Cancer — Colorectal / Colon
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 24590129Source ID: RES-0019
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Cellular Proliferation Regulation
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 15638794Source ID: RES-0065
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Ceramide-Mediated Apoptosis
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 11903061Source ID: RES-0066
Research ContextPreclinical / mechanisticpubmed.ncbi.nlm.nih.gov
Pancreatic Tumor Cell Apoptosis
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 16818650Source ID: RES-0069
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Cannabidiol on the Path from the Lab to the Cancer Patient (2022)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC8951434Source ID: RES-0008
Research ContextScientific sourcenature.com
Clinical and Cognitive Improvement Following Full-Spectrum CBD for Anxiety (2022)
Sleep / Anxiety / QOL · Anxiety · CBD, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
Source ID: RES-0232
Research ContextScientific sourcemdpi.com
The Role of Cannabinoids in Inflammation and Cancer (2021)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · THC, CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
Source ID: RES-0026
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids in Cannabis (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD, THC, Full Spectrum
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC7409346Source ID: RES-0004
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD in Oncology: Current and Future Perspectives (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC7511370Source ID: RES-0006
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD: A Killer for Inflammatory Rheumatoid Arthritis Synovial Fibroblasts (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMID: 32873774PMCID: PMC7463000DOI/ID: 10.1038/s41419-020-02892-1Source ID: RES-0097
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Cannabidiol and Cancer: Therapeutic Potentials and Challenges (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC7456558Source ID: RES-0007
Research ContextScientific sourcemdpi.com
Cannabinoids and Cancer: Therapeutic Possibilities (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · THC, CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
Source ID: RES-0092
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Synergistic Effects of CBD and Chemotherapy in Cancer Treatment (2020)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC7525662Source ID: RES-0027
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
The Entourage Effect: Terpenes Coupled with Cannabinoids (2019)
Anti-Inflammatory · Full Spectrum · Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC6334252Source ID: RES-0201
Research ContextScientific sourcefrontiersin.org
CBD-Rich Cannabis Extracts Superior to Purified CBD in Treatment-Resistant Epilepsy (2018)
Anti-Inflammatory · Epilepsy / Full Spectrum · CBD, Full Spectrum
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
DOI/ID: 10.3389/fneur.2018.00759/fullSource ID: RES-0200
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Cannabinoids as Potential Anticancer Agents — THC/CBD via CB1/CB2 (2015)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · THC, CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC4791144Source ID: RES-0010
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
CBG as Antiproliferative Agent in Colorectal Cancer via TRPM8 (2013)
Oncology / Anti-Proliferative · Cancer — Colorectal / Colon · CBG
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 24675530Source ID: RES-0003
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Cannabinoid Receptor 2: Role in Immunomodulation and Neuroinflammation (2013)
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC3662320Source ID: RES-0053
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
CBD Androgen Receptor Suppression in Prostate Cancer (2012)
Oncology / Anti-Proliferative · Cancer — Prostate · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 23095328Source ID: RES-0011
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Myrcene: Enhances THC Potency via CB1 — Analgesia and Muscle Relaxation (2011)
Anti-Inflammatory · Myrcene · Myrcene, THC
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC3165946Source ID: RES-0202
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Anti-cancer potential: cannabinoids, terpenes, flavonoids
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 32804395Source ID: RES-0016
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Anticancer Mechanisms of Cannabinoids
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 27022311Source ID: RES-0061
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Brahmi (Bacopa monnieri): GABA Modulation, Cortisol Reduction, Cognition
Neuroprotective · Cognition · Brahmi
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 22747190Source ID: RES-0240
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
CBD for Chemotherapy-Induced Peripheral Neuropathy
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMID: 38343646Source ID: RES-0058
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
CBD reduces prostate cancer via androgen receptor
Oncology / Anti-Proliferative · Cancer — Prostate
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 18789600Source ID: RES-0022
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD research source — pmc.ncbi.nlm.nih.gov
Anti-Inflammatory · Anti-Inflammatory · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32231748PMCID: PMC7092763Source ID: RES-0100
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD research source — pmc.ncbi.nlm.nih.gov
Anti-Inflammatory · Anti-Inflammatory · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 30374683PMCID: PMC6223703Source ID: RES-0101
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD research source — pmc.ncbi.nlm.nih.gov
Anti-Inflammatory · Anti-Inflammatory · CBD
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 32159404PMCID: PMC8262682Source ID: RES-0104
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD synergistic with chemo: enhanced efficacy
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC5022434Source ID: RES-0017
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBD: lab to cancer patient - multiple cancers
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC6387667Source ID: RES-0018
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
CBDA more potent than CBD: COX-2 inhibition
Anti-Inflammatory · Inflammation
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 23298862Source ID: RES-0194
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
CBN enhances CBD analgesia in fibromyalgia
Anti-Inflammatory · Fibromyalgia
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC6277878Source ID: RES-0175
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Cancer Pain
Oncology / Anti-Proliferative · Supportive Oncology — Pain
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC2503660Source ID: RES-0035
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoid Signaling in Cancer
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 31332734Source ID: RES-0064
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Cannabinoids in Supportive Cancer Care: Cachexia, Appetite and Weight Restoration
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD, THC
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMID: 37476324Source ID: RES-0077
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Cannabis extract for chronic daily headache / migraine
Anti-Inflammatory · Migraine
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMCID: PMC5159048Source ID: RES-0176
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
ECS in Cancer Biology
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 29663308Source ID: RES-0067
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Cannoflam DS — Full Spectrum Extract
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD + THC 1:1 ratio + terpenes
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 29322089Source ID: RES-0079
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Formulation evidence: Prolifex (Prana) — CBD + THC Synergy
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · CBD + THC + terpenes
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMID: 32234203Source ID: RES-0080
Research ContextScientific sourcenature.com
Full-Spectrum Cannabis Superior to Isolate: Entourage Anti-Cancer Effect
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer · Full Spectrum
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
Source ID: RES-0046
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Full-spectrum cannabis for post-cancer pain
Oncology / Anti-Proliferative · Supportive Oncology — Pain
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
PMCID: PMC5669217Source ID: RES-0096
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
HPA-axis modulation with botanical interventions (Ashwagandha)
Sleep / Anxiety / QOL · Sleep
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 33650944Source ID: RES-0245
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
Head & Neck Cancer Supportive Care
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC12764220Source ID: RES-0060
Research ContextScientific sourcebmj.com
Medical Cannabis for Cancer Pain
Oncology / Anti-Proliferative · Supportive Oncology — Pain
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “May be discussed as supportive oncology symptom-care evidence, not cancer treatment.”
Source ID: RES-0032
Research ContextScientific sourcepmc.ncbi.nlm.nih.gov
QOL Oncology
Oncology / Anti-Proliferative · Cancer — General / Pan-Cancer
Research context — Preclinical oncology/mechanistic; do not claim cancer treatment efficacy
Clinical wording: “Cannabinoids have preclinical/mechanistic oncology signals; human anti-cancer efficacy is not established.”
PMCID: PMC9020711Source ID: RES-0071
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Shatavari (Asparagus racemosus): LH/FSH Regulation, Anti-PCOS Activity
ECS Homeostasis · Hormonal Balance · Shatavari
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 22631691Source ID: RES-0159
Research ContextScientific sourcepubmed.ncbi.nlm.nih.gov
Tulasi (Ocimum sanctum): COX-2 Inhibition, Respiratory Antimicrobial Activity
Anti-Inflammatory · Respiratory Infection · Tulasi
Validated — Scientific source; claim must match endpoint and population
Clinical wording: “Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.”
PMID: 17575270Source ID: RES-0212
No matching evidence card. Try clearing one filter.